LIFR anticorps (C-Term)
Aperçu rapide pour LIFR anticorps (C-Term) (ABIN3028798)
Antigène
Voir toutes LIFR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Antigen affinity purified
-
Immunogène
- This LIFR antibody was produced from a rabbit immunized with a KLH conjugated synthetic peptide between 1021-1055 amino acids from the C-terminal region of human LIFR.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the LIFR antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the LIFR antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))
-
Autre désignation
- LIFR
-
Sujet
- Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells.
-
UniProt
- P42702
-
Pathways
- Signalistation JAK/STAT, Growth Factor Binding
Antigène
-